← Back to Search

Virtual Reality Intervention for Opioid Use Disorder (PARK Trial)

N/A
Recruiting
Led By Brandon G Oberlin, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day visit (day 1); 30-day follow-up visit
Awards & highlights

PARK Trial Summary

This trial will test a VR intervention to see if it lowers opioid use, increases abstinence, & changes self-reported & behavioral focus on future outcomes in opioid users.

Who is the study for?
This trial is for individuals aged 18-60 who are in early recovery from opioid use disorder, having been abstinent for at least 14 days but not more than 6 months. They must be committed to recovery, able to understand English, and can take psychotropic drugs if needed for SUD-related conditions. People cannot join if they've used drugs or alcohol within the last 24 hours before the study visit.Check my eligibility
What is being tested?
The trial is testing a new virtual reality (VR) intervention against a control group with no VR exposure. It aims to see if VR can help reduce opioid use and increase abstinence periods over a month follow-up by enhancing future-oriented thinking and preference for delayed rewards among participants.See study design
What are the potential side effects?
Since this is a non-invasive VR intervention, side effects may include discomfort like dizziness or nausea related to VR usage. However, specific side effects will depend on individual reactions to virtual reality environments.

PARK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day visit (day 1); 30-day follow-up visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and study day visit (day 1); 30-day follow-up visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Overall Abstinence
Delayed Reward
Future Self-Identification
+3 more

PARK Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Virtual RealityExperimental Treatment2 Interventions
Participants in this arm will receive the following interventions: Treatment As Usual (Empty Virtual Reality Park) Virtual Reality Avatar (Intervention)
Group II: Treatment As Usual (Control)Placebo Group1 Intervention
Participants in this arm will receive the following interventions: Treatment As Usual (Empty Virtual Reality Park)

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,562 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,531 Total Patients Enrolled
Brandon G Oberlin, PhDPrincipal InvestigatorIndiana University
3 Previous Clinical Trials
686 Total Patients Enrolled

Media Library

Virtual Reality Avatar Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05908097 — N/A
Opioid Use Disorder Research Study Groups: Virtual Reality, Treatment As Usual (Control)
Opioid Use Disorder Clinical Trial 2023: Virtual Reality Avatar Intervention Highlights & Side Effects. Trial Name: NCT05908097 — N/A
Virtual Reality Avatar Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908097 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial include individuals who have exceeded the age of 35?

"This research trial is open to those aged between 18 and 60. For minors, there are 97 relevant studies whereas for seniors over 65 years old, 501 related trials exist."

Answered by AI

How many participants are accepted to this medical experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is still actively recruiting participants and was initially posted on April 4th 2023 with the most recent update being June 8th of that same year. A total of 200 individuals need to be recruited from two separate centres."

Answered by AI

Does this medical trial still have vacancies for participants?

"The trial is still open to applicants, as evidenced by the clinicaltrials.gov listing which was first published on April 4th 2023 and last amended on June 8th of this year."

Answered by AI

Could I join the research study being conducted?

"This clinical trial requires participants to be between 18 and 60 years of age, suffering from opioid use disorder. In total, the team is looking for 200 individuals who meet this criteria."

Answered by AI
~50 spots leftby Sep 2024